Aletha Maybank, MD, MPH recently joined the AMA in April 2019 as their inaugural Chief Health Equity Officer and Vice President. Her role is to embed health equity in all the work of the AMA and to launch a Center for Health Equity.
Prior to this in 2014, Dr. Maybank became an Associate Commissioner, and later a Deputy Commissioner, and lunched the Center for Health Equity, a new division in the NYC Department of Health and Mental Hygiene geared toward strengthening and amplifying the Health Department’s work in ending health inequities. Under her leadership, and in a short amount of time, the health department made great strides in transforming the culture and public health practice by embedding health equity in the health department’s work. This work has been recognized and adapted by other City agencies and has captured the attention of the CDC and WHO.
She also teaches medical and public health students on topics related to health inequities, public health leadership and management, physician advocacy, and community organizing health. Currently, Dr. Maybank serves as President of the Empire State Medical Association, the NYS affiliate of the National Medical Association. In 2012, she co-founded “We Are Doc McStuffins,” a movement created by African-American female physicians who are inspired by the Disney Junior character, Doc McStuffins.
Dr. Maybank holds a BA from Johns Hopkins University, an MD from Temple University School of Medicine, and an MPH from Columbia University Mailman School of Public Health. She is a pediatrician and board certified in Preventive Medicine and Public Health.
Lunch Plenary:
A Commitment to Advance Health Equity
Anticipating Hospital Bed Shortages, States Suspend Certificate of Need Programs to Allow Quick Expansions
/in COVID-19 State Action Center Blogs, Featured News Home Community Benefit, COVID-19, Health System Costs, Hospital/Health System Oversight, Population Health /by Deborah Fournier, Adney Rakotoniaina and Johanna ButlerAs coronavirus (COVID-19) hospitalizations and ICU bed demand surge across the country, 13 states have quickly acted to implement temporary, targeted suspensions of their certificate of need (CON) requirements for construction or expansion of new health-care facilities to remove regulatory barriers to address this critical health care need. CON laws are state regulatory mechanisms to […]
Federal Guidance Needed to Clarify CARES Act Health Coverage Provisions
/in COVID-19 State Action Center Blogs, Featured News Home Consumer Affordability, COVID-19, Health Coverage and Access, Health System Costs, State Insurance Marketplaces /by Christina Cousart and Anita CardwellAs unemployment rates rapidly rise and more individuals seek new health coverage options, states are preparing for an influx of new Medicaid and insurance marketplace enrollees. While the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) provides significant support for a broad array of services, its $600 a week in additional unemployment compensation could […]
States Address Provider Shortages to Meet the Health Care Demands of the Pandemic
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Health Coverage and Access, Population Health, Workforce Capacity /by Ariella Levisohn and Elinor HigginsAs states mobilize to meet the crushing health care demands resulting from the COVID-19 pandemic, policymakers are increasing the flexibility and capacity of their health care systems. One strategy is to address provider shortages that existed even before the pandemic by loosening health care licensing requirements and expanding scope-of-practice rules. As states work to address […]
States with Transparency Laws Monitor Prices of Potential COVID-19 Drug Treatments
/in COVID-19 State Action Center Blogs, Featured News Home Administrative Actions, COVID-19, Legal Resources, Prescription Drug Pricing, State Rx Legislative Action COVID-19 /by Johanna Butler and Jennifer ReckAbsent sufficient evidence from clinical trials that proves a variety of drugs are effective against COVID-19, many states are providing guidance to limit their use and have begun monitoring them for price increases and shortages. Building on experience from states’ drug price transparency laws, policymakers now have tools to track these drug costs and identify […]
State Medicaid Strategies to Maintain Access to Care for Children with Special Health Care Needs during the Pandemic
/in COVID-19 State Action Center Blogs, Featured News Home Children/Youth with Special Health Care Needs, Children/Youth with Special Health Care Needs, Chronic and Complex Populations, COVID-19, Maternal, Child, and Adolescent Health /by Kate Honsberger and Karen VanLandeghemStates and the federal government are taking unprecedented steps to address the health needs of individuals impacted by COVID-19, including children and adults with chronic and complex health care conditions who are vulnerable to infection and to changes in the health care delivery system that may impact their ability to access much-needed primary and specialty […]
CARES Act in the States: Targeting New Health Funding in a Time of Crisis
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Eligibility and Enrollment, Health Coverage and Access, Health Equity, Housing and Health, Medicaid Managed Care, Population Health, Relief and Recovery, Social Determinants of Health, Workforce Capacity /by Trish Riley and Ellen SchneiterThe landmark $2 trillion Coronavirus Aid, Relief and Economic Security Act (CARES), enacted last week, includes critically important new funding to help states in their fight to combat COVID-19. Governors and legislatures, most adjourned to comply with social distancing bans on public gatherings, will need to make quick but informed decisions about how best to […]
States Act to Increase Medicaid/Marketplace Coverage to Insulate Consumers from COVID-19 Care Costs
/in COVID-19 State Action Center Blogs, Featured News Home Consumer Affordability, COVID-19, Eligibility and Enrollment, Essential Health Benefits, Health Coverage and Access, Health System Costs, Medicaid Expansion, State Insurance Marketplaces COVID-19 /by Christina CousartDuring this public health emergency, new federal laws (HR 6201, HR 748) are making significant steps to eliminate consumer cost-sharing for coronavirus (COVID-19) testing, diagnosis, and prevention while states are working to increase insurance access and surprise billing protections. The recently passed Families First Coronavirus Response Act includes several provisions that expand the ability of Medicaid and the […]
States Modify Medicaid Home- and Community-Based Waivers to Respond to COVID-19
/in The RAISE Act Family Caregiver Resource and Dissemination Center Blogs, Featured News Home Chronic and Complex Populations, Community Health Workers, COVID-19, Health Equity, Long-Term Care, Physical and Behavioral Health Integration, Population Health, State Resources, The RAISE Family Caregiver Resource and Dissemination Center /by Wendy Fox-GrageStates are working rapidly to ensure that individuals with complex medical conditions and their families have access to necessary home- and community-based services during the coronavirus (COVID-19) crisis. Under new federal rules, states can now temporarily amend programs serving Medicaid enrollees using long-term services and supports through waiver and state plan amendment applications. The US […]
States Can Use CARES Act Funding to Support Health-Related Social Needs Exacerbated by COVID-19 Pandemic
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Health Equity, Housing and Health, Population Health, Relief and Recovery, Social Determinants of Health /by Rebecca Cooper and Jill RosenthalStates Act to Protect Consumers against Unproven COVID-19 Drugs and Safeguard Supplies as FDA Approves Limited Use
/in COVID-19 State Action Center Blogs, Featured News Home Administrative Actions, Consumer Affordability, COVID-19, Health System Costs, Prescription Drug Pricing /by Trish Riley and Sarah LanfordAt least 11 states have acted to limit the dispensing of chloroquine and hydroxychloroquine – prescription drugs that have been cited as providing protection against coronavirus (COVID-19) without adequate clinical evidence to support that claim. To protect consumers with or at risk of COVID-19 and to prevent stockpiling of these drugs, which treat malaria, rheumatoid […]